Socialiya - Entertainment. Knowledge. Community.
ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta

Three times as many deaths in the study arm vs. the control arm in a trial of ADC's Zynlonta have ra...

BUSINESS NEWS June 04, 2026

ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta

Three times as many deaths in the study arm vs. the control arm in a trial of ADC's Zynlonta have raised questions about the antibody-drug conjugate.

2 views 0 likes 0 comments
Share:
Three times as many deaths in the study arm vs. the control arm in a trial of ADC's Zynlonta have raised questions about the antibody-drug conjugate.

Author: Fierce Pharma

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya